Yunxia Wang Selected Research

Yunxia Wang Research Topics

Disease

20	Neoplasms (Cancer) 04/2022 - 08/2011
6	Inflammation (Inflammations) 01/2020 - 04/2009
5	Bacterial Infections (Bacterial Infection) 09/2020 - 10/2018
5	Infections 09/2020 - 04/2009
4	Abdominal Aortic Aneurysm 12/2022 - 01/2017
4	Wounds and Injuries (Trauma) 03/2020 - 07/2011
4	Myocardial Ischemia (Ischemic Heart Diseases) 11/2019 - 01/2008
4	Chronic Obstructive Pulmonary Disease (COPD) 05/2019 - 01/2018
4	Myotonia 07/2013 - 07/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2017
3	Lung Neoplasms (Lung Cancer) 06/2021 - 09/2017
3	Neoplasm Metastasis (Metastasis) 02/2020 - 01/2020
3	Disease Progression 01/2019 - 01/2015
3	Fibrosis (Cirrhosis) 08/2018 - 10/2014
3	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 10/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2021
2	Diabetes Mellitus 01/2021 - 01/2020
2	Pain (Aches) 01/2021 - 01/2008
2	Colonic Neoplasms (Colon Cancer) 02/2020 - 01/2020
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2011
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Atherosclerosis 01/2020 - 12/2019
2	Hypoxia (Hypoxemia) 01/2019 - 10/2014
2	Cholangiocarcinoma 01/2019 - 01/2016
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2015
2	Non-alcoholic Fatty Liver Disease 11/2017 - 08/2017
2	Headache (Headaches) 03/2017 - 02/2017
2	Tuberculosis (Tuberculoses) 03/2016 - 08/2015
2	Rare Diseases (Rare Disease) 07/2013 - 10/2012
2	Neuralgia (Stump Neuralgia) 09/2011 - 09/2008
2	Leukemia 12/2002 - 11/2002
1	Rupture 12/2022
1	Oligomenorrhea 12/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Cholestasis 11/2021
1	Heart Failure 09/2021
1	Cardiotoxicity 09/2021
1	Carcinogenesis 06/2021
1	Hyperplasia 06/2021
1	Myocardial Infarction 01/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2021 - 05/2008
10	Pharmaceutical PreparationsIBA 12/2022 - 02/2008
9	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2014
7	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2013
5	PolymersIBA 03/2020 - 10/2018
5	Messenger RNA (mRNA)IBA 01/2019 - 01/2008
5	EnzymesIBA 04/2012 - 05/2008
4	Particulate MatterIBA 11/2019 - 01/2018
4	Sodium Channels (Sodium Channel)IBA 07/2013 - 07/2011
3	Circular RNAIBA 09/2021 - 11/2019
3	Purinergic P2X3 ReceptorsIBA 11/2019 - 05/2008
3	CollagenIBA 08/2018 - 01/2015
3	ARQ 197IBA 01/2018 - 11/2016
3	CytokinesIBA 03/2016 - 01/2015
2	naringeninIBA 12/2022 - 08/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2022 - 08/2018
2	Therapeutic UsesIBA 01/2021 - 06/2018
2	VimentinIBA 02/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 02/2020 - 01/2015
2	Long Noncoding RNAIBA 02/2020 - 01/2020
2	Pancreatic Elastase (Elastase)IBA 01/2020 - 01/2017
2	PolyphenolsIBA 01/2020 - 01/2017
2	ElastinIBA 01/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2019
2	InflammasomesIBA 11/2019 - 08/2018
2	SmokeIBA 05/2019 - 01/2018
2	rasagiline (Azilect)FDA Link 01/2019 - 01/2015
2	Monoamine Oxidase (MAO)IBA 01/2019 - 01/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 07/2011
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 07/2011
2	Sirtuin 1IBA 01/2019 - 11/2017
2	cycloastragenolIBA 01/2019 - 08/2018
2	derazantinibIBA 01/2019 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 04/2009
2	Choline (Choline Chloride)IBA 08/2017 - 11/2015
2	Adenosine Triphosphate (ATP)IBA 01/2016 - 01/2008
2	SodiumIBA 07/2013 - 08/2011
2	ChloridesIBA 07/2013 - 07/2011
2	NAD (NADH)IBA 09/2011 - 12/2002
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2010 - 04/2009
2	Tryptophan (L-Tryptophan)FDA Link 02/2010 - 04/2009
2	A-317491IBA 05/2008 - 01/2008
1	isonicotinamideIBA 12/2022
1	Circulating Tumor DNAIBA 04/2022
1	Biocompatible Materials (Biomaterials)IBA 03/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	pirfenidoneIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022
1	InterleukinsIBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	Nucleic AcidsIBA 03/2021
1	Indicators and Reagents (Reagents)IBA 01/2021

Therapy/Procedure

13	Therapeutics 03/2022 - 08/2011
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2015
2	Endovascular Procedures 03/2017 - 02/2017
1	Length of Stay 12/2022
1	Acupressure (Shiatsu) 01/2021